{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:02:43Z","timestamp":1791291763698,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,16]]},"DOI":"10.7759\/cureus.82350","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T08:59:16Z","timestamp":1744793956000},"source":"Crossref","is-referenced-by-count":19,"title":["A Systematic Review of Inflammatory Markers in Polycystic Ovary Syndrome (PCOS) and Meta-Analysis of Interleukin-6 (IL-6) in Case-Control Studies"],"prefix":"10.7759","author":[{"given":"Bhavit","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avelyn","family":"Thazhuthadath Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasikala","family":"Kathiresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzina","family":"Farook Ghachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetapadma","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheuli","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khyati","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sauvit","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalitha Soumya","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"V P","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delna","family":"NS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajita","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13091559","article-title":"Polycystic ovary syndrome: pathophysiology and controversies in diagnosis","volume":"13","author":"Fahs D","year":"2023","unstructured":"Fahs D, Salloum D, Nasrallah M, Ghazeeri G. Polycystic ovary syndrome: pathophysiology and controversies in diagnosis. Diagnostics (Basel). 2023, 13:1559. 10.3390\/diagnostics13091559","journal-title":"Diagnostics (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-017-1047-7","article-title":"Polycystic ovary syndrome throughout a woman's life","volume":"35","author":"Bellver J","year":"2018","unstructured":"Bellver J, Rodr\u00edguez-Tabernero L, Robles A, et al.. Polycystic ovary syndrome throughout a woman's life. J Assist Reprod Genet. 2018, 35:25-39. 10.1007\/s10815-017-1047-7","journal-title":"J Assist Reprod Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29912","article-title":"Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome","volume":"236","author":"Rostamtabar M","year":"2021","unstructured":"Rostamtabar M, Esmaeilzadeh S, Tourani M, et al.. Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome. J Cell Physiol. 2021, 236:824-38. 10.1002\/jcp.29912","journal-title":"J Cell Physiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.9734\/ajmah\/2024\/v22i71058","article-title":"The intersection of hepcidin and polycystic ovary syndrome: a review of current understanding","volume":"22","author":"Athira PR","year":"2024","unstructured":"Athira PR, Swathi D, Sukesh, Pillai A, Delna NS. The intersection of hepcidin and polycystic ovary syndrome: a review of current understanding. Asian J Med Health. 2024, 22:174-81. 10.9734\/ajmah\/2024\/v22i71058","journal-title":"Asian J Med Health"},{"key":"ref5","article-title":"Serum leptin levels in predicting polycystic ovary syndrome (PCOS)","volume":"23","author":"Sushitha ES","year":"2024","unstructured":"Sushitha ES, Prajna P Shetty, Kathiresan S, et al.. Serum leptin levels in predicting polycystic ovary syndrome (PCOS). Am J Biomed Sci Res. 2024, 23:3.","journal-title":"Am J Biomed Sci Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-21416-0","article-title":"Meta-Analysis With R","author":"Schwarzer G","year":"2015","unstructured":"Schwarzer G, Carpenter JR, R\u00fccker G. Meta-Analysis With R. Springer, Cham; 2015. 10.1007\/978-3-319-21416-0"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.12.049","article-title":"The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome","volume":"229","author":"Jamilian M","year":"2018","unstructured":"Jamilian M, Shojaei A, Samimi M, et al.. The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome. J Affect Disord. 2018, 229:41-7. 10.1016\/j.jad.2017.12.049","journal-title":"J Affect Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13239","article-title":"Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome","volume":"86","author":"Sathyapalan T","year":"2017","unstructured":"Sathyapalan T, Javed Z, Kilpatrick ES, Coady AM, Atkin SL. Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2017, 86:384-7. 10.1111\/cen.13239","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7977","article-title":"The effects of propolis supplementation on high-sensitivity C-reactive protein, testosterone hormone, and metabolic profile in women with polycystic ovary syndrome: a randomized, triple-blinded, placebo-controlled clinical trial","volume":"37","author":"Abbasi E","year":"2023","unstructured":"Abbasi E, Bagherniya M, Soleimani D, Ghasemi-Tehrani H, Abbaspour M, Clark CC, Askari G. The effects of propolis supplementation on high-sensitivity C-reactive protein, testosterone hormone, and metabolic profile in women with polycystic ovary syndrome: a randomized, triple-blinded, placebo-controlled clinical trial. Phytother Res. 2023, 37:5366-77. 10.1002\/ptr.7977","journal-title":"Phytother Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13186","article-title":"Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers","volume":"83","author":"Brenjian S","year":"2020","unstructured":"Brenjian S, Moini A, Yamini N, et al.. Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers. Am J Reprod Immunol. 2020, 83:e13186. 10.1111\/aji.13186","journal-title":"Am J Reprod Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18464","article-title":"Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress-apoptosis gene expression in PBMCs of women with PCOS","volume":"28","author":"Jabarpour M","year":"2024","unstructured":"Jabarpour M, Amidi F, Aleyasin A, Nashtaei MS, Marghmaleki MS. Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress-apoptosis gene expression in PBMCs of women with PCOS. J Cell Mol Med. 2024, 28:e18464. 10.1111\/jcmm.18464","journal-title":"J Cell Mol Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202205_28845","article-title":"Effect of aerobic exercise on inflammatory markers in polycystic ovary syndrome: a randomized controlled trial","volume":"26","author":"Elbandrawy AM","year":"2022","unstructured":"Elbandrawy AM, Yousef AM, Morgan EN, Ewais NF, Eid MM, Elkholi SM, Abdelbasset WK. Effect of aerobic exercise on inflammatory markers in polycystic ovary syndrome: a randomized controlled trial. Eur Rev Med Pharmacol Sci. 2022, 26:3506-13. 10.26355\/eurrev_202205_28845","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01504-0","article-title":"Astaxanthin treatment decreases pro-inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: a randomized clinical trial","volume":"32","author":"Fereidouni F","year":"2024","unstructured":"Fereidouni F, Kashani L, Amidi F, Khodarahmian M, Zhaeentan S, Ardehjani NA, Rastegar T. Astaxanthin treatment decreases pro-inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: a randomized clinical trial. Inflammopharmacology. 2024, 32:2337-47. 10.1007\/s10787-024-01504-0","journal-title":"Inflammopharmacology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7474","article-title":"Effects of crocin supplementation on inflammatory markers, lipid profiles, insulin and cardioprotective indices in women with PCOS: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Rahimi G","year":"2022","unstructured":"Rahimi G, Shams S, Aslani MR. Effects of crocin supplementation on inflammatory markers, lipid profiles, insulin and cardioprotective indices in women with PCOS: a randomized, double-blind, placebo-controlled trial. Phytother Res. 2022, 36:2605-15. 10.1002\/ptr.7474","journal-title":"Phytother Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3290\/j.qi.b5751228","article-title":"Effect of ethinyl estradiol\/norethisterone acetate with and without scaling on periodontal status and high-sensitivity C-reactive protein levels in women with polycystic ovary syndrome having gingivitis: a randomized controlled trial","volume":"55","author":"Verma R","year":"2024","unstructured":"Verma R, Tewari S, Singhal SR, Sangwan A. Effect of ethinyl estradiol\/norethisterone acetate with and without scaling on periodontal status and high-sensitivity C-reactive protein levels in women with polycystic ovary syndrome having gingivitis: a randomized controlled trial. Quintessence Int. 2024, 55:792-802. 10.3290\/j.qi.b5751228","journal-title":"Quintessence Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1376990","article-title":"DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial","volume":"47","author":"Asemi Z","year":"2015","unstructured":"Asemi Z, Esmaillzadeh A. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial. Horm Metab Res. 2015, 47:232-8. 10.1055\/s-0034-1376990","journal-title":"Horm Metab Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-019-01715-5","article-title":"The effects of selenium supplementation on clinical symptoms and gene expression related to inflammation and vascular endothelial growth factor in infertile women candidate for in vitro fertilization","volume":"193","author":"Heidar Z","year":"2020","unstructured":"Heidar Z, Hamzepour N, Zadeh Modarres S, Mirzamoradi M, Aghadavod E, Pourhanifeh MH, Asemi Z. The effects of selenium supplementation on clinical symptoms and gene expression related to inflammation and vascular endothelial growth factor in infertile women candidate for in vitro fertilization. Biol Trace Elem Res. 2020, 193:319-25. 10.1007\/s12011-019-01715-5","journal-title":"Biol Trace Elem Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0248-0","article-title":"The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"18","author":"Nasri K","year":"2018","unstructured":"Nasri K, Jamilian M, Rahmani E, Bahmani F, Tajabadi-Ebrahimi M, Asemi Z. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. BMC Endocr Disord. 2018, 18:21. 10.1186\/s12902-018-0248-0","journal-title":"BMC Endocr Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01139-x","article-title":"The effect of synbiotics pomegranate juice on cardiovascular risk factors in PCOS patients: a randomized, triple-blinded, controlled trial","volume":"43","author":"Esmaeilinezhad Z","year":"2020","unstructured":"Esmaeilinezhad Z, Barati-Boldaji R, Brett NR, de Zepetnek JO, Bellissimo N, Babajafari S, Sohrabi Z. The effect of synbiotics pomegranate juice on cardiovascular risk factors in PCOS patients: a randomized, triple-blinded, controlled trial. J Endocrinol Invest. 2020, 43:539-48. 10.1007\/s40618-019-01139-x","journal-title":"J Endocrinol Invest"},{"key":"ref20","article-title":"Polycystic ovary syndrome and circulating inflammatory markers","volume":"15","author":"Zangeneh FZ","year":"2017","unstructured":"Zangeneh FZ, Naghizadeh MM, Masoumi M. Polycystic ovary syndrome and circulating inflammatory markers. Int J Reprod Biomed. 2017, 15:375.","journal-title":"Int J Reprod Biomed"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14684","article-title":"Role of inflammatory markers in polycystic ovaries syndrome: in relation to insulin resistance","volume":"47","author":"Alissa EM","year":"2021","unstructured":"Alissa EM, Algarni SA, Khaffji AJ, Al Mansouri NM. Role of inflammatory markers in polycystic ovaries syndrome: in relation to insulin resistance. J Obstet Gynaecol Res. 2021, 47:1409-15. 10.1111\/jog.14684","journal-title":"J Obstet Gynaecol Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2014.10.028","article-title":"Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise","volume":"124","author":"Covington JD","year":"2016","unstructured":"Covington JD, Tam CS, Pasarica M, Redman LM. Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise. Biochimie. 2016, 124:27-33. 10.1016\/j.biochi.2014.10.028","journal-title":"Biochimie"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5489523","article-title":"Significant improvement selected mediators of inflammation in phenotypes of women with PCOS after reduction and low GI diet","volume":"2017","author":"Szczuko M","year":"2017","unstructured":"Szczuko M, Zapa\u0142owska-Chwy\u0107 M, Maciejewska D, Drozd A, Starczewski A, Stachowska E. Significant improvement selected mediators of inflammation in phenotypes of women with PCOS after reduction and low GI diet. Mediators Inflamm. 2017, 2017:5489523. 10.1155\/2017\/5489523","journal-title":"Mediators Inflamm"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4092470","article-title":"Inflammatory markers in women with polycystic ovary syndrome","volume":"2020","author":"Rudnicka E","year":"2020","unstructured":"Rudnicka E, Kunicki M, Suchta K, Machura P, Grymowicz M, Smolarczyk R. Inflammatory markers in women with polycystic ovary syndrome. Biomed Res Int. 2020, 2020:4092470. 10.1155\/2020\/4092470","journal-title":"Biomed Res Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2015.06.022","article-title":"Obesity and inflammatory biomarkers in women with polycystic ovary syndrome","volume":"192","author":"Shen SH","year":"2015","unstructured":"Shen SH, Shen SY, Liou TH, et al.. Obesity and inflammatory biomarkers in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2015, 192:66-71. 10.1016\/j.ejogrb.2015.06.022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-014-3199-3","article-title":"The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case-control study","volume":"290","author":"Keskin Kurt R","year":"2014","unstructured":"Keskin Kurt R, Okyay AG, Hakverdi AU, Gungoren A, Dolapcioglu KS, Karateke A, Dogan MO. The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case-control study. Arch Gynecol Obstet. 2014, 290:315-9. 10.1007\/s00404-014-3199-3","journal-title":"Arch Gynecol Obstet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102791","article-title":"Inflammatory and anti-inflammatory parameters in PCOS patients depending on body mass index: a case-control study","volume":"11","author":"Vasyukova E","year":"2023","unstructured":"Vasyukova E, Zaikova E, Kalinina O, et al.. Inflammatory and anti-inflammatory parameters in PCOS patients depending on body mass index: a case-control study. Biomedicines. 2023, 11:2791. 10.3390\/biomedicines11102791","journal-title":"Biomedicines"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.10.035","article-title":"Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome","volume":"103","author":"Pedroso DC","year":"2015","unstructured":"Pedroso DC, Miranda-Furtado CL, Kogure GS, et al.. Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome. Fertil Steril. 2015, 103:542-7.e2. 10.1016\/j.fertnstert.2014.10.035","journal-title":"Fertil Steril"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-01972-3","article-title":"Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome","volume":"65","author":"Demi R \u0130","year":"2019","unstructured":"Demi R \u0130, Guler A, Alarslan P, Isil AM, Ucman O, Aslanipour B, Calan M. Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome. Endocrine. 2019, 65:175-83. 10.1007\/s12020-019-01972-3","journal-title":"Endocrine"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.12659\/msm.901194","article-title":"Altered circulating inflammatory cytokines are associated with anovulatory polycystic ovary syndrome (PCOS) women resistant to clomiphene citrate treatment","volume":"23","author":"Wang L","year":"2017","unstructured":"Wang L, Qi H, Baker PN, et al.. Altered circulating inflammatory cytokines are associated with anovulatory polycystic ovary syndrome (PCOS) women resistant to clomiphene citrate treatment. Med Sci Monit. 2017, 23:1083-9. 10.12659\/msm.901194","journal-title":"Med Sci Monit"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2017.02.012","article-title":"Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte-endothelium interactions in PCOS","volume":"71","author":"Ba\u00f1uls C","year":"2017","unstructured":"Ba\u00f1uls C, Rovira-Llopis S, Martinez de Mara\u00f1on A, et al.. Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte-endothelium interactions in PCOS. Metabolism. 2017, 71:153-62. 10.1016\/j.metabol.2017.02.012","journal-title":"Metabolism"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.31832\/smj.855493","article-title":"Endocan as a potential marker of early endothelial dysfunction in polycystic ovary syndrome (PCOS)","volume":"11","author":"Apayd\u0131n M","year":"2021","unstructured":"Apayd\u0131n M, Demirci T, \u00c7akal E. Endocan as a potential marker of early endothelial dysfunction in polycystic ovary syndrome (PCOS). Sakarya T\u0131p Dergisi. 2021, 11:155-61. 10.31832\/smj.855493","journal-title":"Sakarya T\u0131p Dergisi"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2016.12.020","article-title":"Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization","volume":"91","author":"Niu Z","year":"2017","unstructured":"Niu Z, Ye Y, Xia L, Feng Y, Zhang A. Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization. Cytokine. 2017, 91:180-6. 10.1016\/j.cyto.2016.12.020","journal-title":"Cytokine"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20211215","article-title":"The relation of dermcidin with insulin resistance and inflammation in women with polycystic ovary syndrome","volume":"68","author":"Akan OY","year":"2022","unstructured":"Akan OY, Bilgir O. The relation of dermcidin with insulin resistance and inflammation in women with polycystic ovary syndrome. Rev Assoc Med Bras (1992). 2022, 68:820-6. 10.1590\/1806-9282.20211215","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2016.17.3.1583","article-title":"The ICAM-1 Gly241Arg polymorphism is not associated with polycystic ovary syndrome - results from a case control study in Kashmir, India","volume":"17","author":"Yousuf SD","year":"2016","unstructured":"Yousuf SD, Ganie MA, Zargar MA, Parvez T, Rashid F. The ICAM-1 Gly241Arg polymorphism is not associated with polycystic ovary syndrome - results from a case control study in Kashmir, India. Asian Pac J Cancer Prev. 2016, 17:1583-8. 10.7314\/apjcp.2016.17.3.1583","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2016.1256966","article-title":"The effects of IL-1A and IL-6 genes polymorphisms on gene expressions, hormonal and biochemical parameters in polycystic ovary syndrome","volume":"37","author":"Eser B","year":"2017","unstructured":"Eser B, Islimye Taskin M, Hismiogullari AA, Aksit H, Bodur AS. The effects of IL-1A and IL-6 genes polymorphisms on gene expressions, hormonal and biochemical parameters in polycystic ovary syndrome. J Obstet Gynaecol. 2017, 37:358-62. 10.1080\/01443615.2016.1256966","journal-title":"J Obstet Gynaecol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.18502\/ijrm.v19i4.9057","article-title":"Chronic inflammation in polycystic ovary syndrome: a case-control study using multiple markers","volume":"19","author":"Goswami S","year":"2021","unstructured":"Goswami S, Choudhuri S, Bhattacharya B, et al.. Chronic inflammation in polycystic ovary syndrome: a case-control study using multiple markers. Int J Reprod Biomed. 2021, 19:313-20. 10.18502\/ijrm.v19i4.9057","journal-title":"Int J Reprod Biomed"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165033","article-title":"Biomarker profiles in women with PCOS and PCOS offspring; a pilot study","volume":"11","author":"Daan NM","year":"2016","unstructured":"Daan NM, Koster MP, de Wilde MA, Dalmeijer GW, Evelein AM, Fauser BC, de Jager W. Biomarker profiles in women with PCOS and PCOS offspring; a pilot study. PLoS One. 2016, 11:e0165033. 10.1371\/journal.pone.0165033","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9093024","article-title":"Effect of central obesity and hyperandrogenism on selected inflammatory markers in patients with PCOS: a WHtR-matched case-control study","volume":"9","author":"Ka\u0142u\u017cna M","year":"2020","unstructured":"Ka\u0142u\u017cna M, Cz\u0142apka-Matyasik M, Wachowiak-Ochma\u0144ska K, et al.. Effect of central obesity and hyperandrogenism on selected inflammatory markers in patients with PCOS: a WHtR-matched case-control study. J Clin Med. 2020, 9:3024. 10.3390\/jcm9093024","journal-title":"J Clin Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2017.05.014","article-title":"The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women","volume":"214","author":"Tola EN","year":"2017","unstructured":"Tola EN, Yalcin SE, Dugan N. The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women. Eur J Obstet Gynecol Reprod Biol. 2017, 214:168-72. 10.1016\/j.ejogrb.2017.05.014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1055\/a-0992-9114","article-title":"Association between biomarkers of low-grade inflammation and sex hormones in women with polycystic ovary syndrome","volume":"128","author":"Hatziagelaki E","year":"2020","unstructured":"Hatziagelaki E, Pergialiotis V, Kannenberg JM, et al.. Association between biomarkers of low-grade inflammation and sex hormones in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2020, 128:723-30. 10.1055\/a-0992-9114","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.13005\/bpj\/1829","article-title":"A cross sectional study on the status of inflammatory markers in polycystic ovary syndrome (PCOS) in Indian population","volume":"12","author":"Ramamoorthy S","year":"2019","unstructured":"Ramamoorthy S, Bhuvaneswari K. A cross sectional study on the status of inflammatory markers in polycystic ovary syndrome (PCOS) in Indian population. Biomed Pharmacol J. 2019, 12:1975-83. 10.13005\/bpj\/1829","journal-title":"Biomed Pharmacol J"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-2-3","article-title":"Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study","volume":"2","author":"Giallauria F","year":"2009","unstructured":"Giallauria F, Orio F, Lombardi G, Colao A, Vigorito C, Tafuri MG, Palomba S. Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study. J Ovarian Res. 2009, 2:3. 10.1186\/1757-2215-2-3","journal-title":"J Ovarian Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13808","article-title":"Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS","volume":"89","author":"Shorakae S","year":"2018","unstructured":"Shorakae S, Ranasinha S, Abell S, Lambert G, Lambert E, de Courten B, Teede H. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol (Oxf). 2018, 89:628-33. 10.1111\/cen.13808","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.20473\/mog.v30i22022.66-71","article-title":"Inflammatory markers in lean polycystic ovary syndrome subjects are not associated with the spectrum of dyslipidemia","volume":"30","author":"Atnil E","year":"2022","unstructured":"Atnil E, Hestiantoro A, Riayati O, Febri RR, Muna N. Inflammatory markers in lean polycystic ovary syndrome subjects are not associated with the spectrum of dyslipidemia. Majalah Obstetri Ginekologi. 2022, 30:66-71. 10.20473\/mog.v30i22022.66-71","journal-title":"Majalah Obstetri Ginekologi"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000716","article-title":"Association between dry eye and polycystic ovary syndrome: subclinical inflammation may be part of the process","volume":"47","author":"Asfuro\u011flu Y","year":"2021","unstructured":"Asfuro\u011flu Y, Kan \u00d6, Asfuro\u011flu M, Baser E. Association between dry eye and polycystic ovary syndrome: subclinical inflammation may be part of the process. Eye Contact Lens. 2021, 47:27-31. 10.1097\/ICL.0000000000000716","journal-title":"Eye Contact Lens"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1080\/07435800.2016.1255896","article-title":"Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome","volume":"42","author":"Bicer M","year":"2017","unstructured":"Bicer M, Guler A, Unal Kocabas G, et al.. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome. Endocr Res. 2017, 42:145-53. 10.1080\/07435800.2016.1255896","journal-title":"Endocr Res"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.4103\/1735-1995.172813","article-title":"Apolipoprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome: a case-control study","volume":"20","author":"Amjadi F","year":"2015","unstructured":"Amjadi F, Aflatoonian R, Javanmard SH, Saifi B, Ashrafi M, Mehdizadeh M. Apolipoprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome: a case-control study. J Res Med Sci. 2015, 20:1039-45. 10.4103\/1735-1995.172813","journal-title":"J Res Med Sci"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.5603\/GP.a2017.0095","article-title":"Increased serum neuregulin 4 levels in women with polycystic ovary syndrome. A case-control study","volume":"88","author":"Temur M","year":"2017","unstructured":"Temur M, Calan M, Ak\u015fit M, et al.. Increased serum neuregulin 4 levels in women with polycystic ovary syndrome. A case-control study. Ginekol Pol. 2017, 88:517-22. 10.5603\/GP.a2017.0095","journal-title":"Ginekol Pol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2016.1190760","article-title":"Adipokines and soluble cell adhesion molecules in insulin resistant and non-insulin resistant women with polycystic ovary syndrome","volume":"122","author":"Koleva DI","year":"2016","unstructured":"Koleva DI, Orbetzova MM, Nikolova JG, Tyutyundzhiev SB. Adipokines and soluble cell adhesion molecules in insulin resistant and non-insulin resistant women with polycystic ovary syndrome. Arch Physiol Biochem. 2016, 122:223-7. 10.1080\/13813455.2016.1190760","journal-title":"Arch Physiol Biochem"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.61505\/evidence.2023.1.1.7","article-title":"Steps in undertaking meta-analysis and addressing heterogeneity in meta-analysis","volume":"1","author":"Gandhi AP","year":"2023","unstructured":"Gandhi AP, Shamim MA, Padhi BK. Steps in undertaking meta-analysis and addressing heterogeneity in meta-analysis. Evidence. 2023, 1:78-92. 10.61505\/evidence.2023.1.1.7","journal-title":"Evidence"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66570","article-title":"Biomarkers of oxidative stress and their clinical relevance in type 2 diabetes mellitus patients: a systematic review","volume":"16","author":"S S","year":"2024","unstructured":"S S, Hegde SV, Agarwal SV, Ns D, Pillai A, Shah SN, S R. Biomarkers of oxidative stress and their clinical relevance in type 2 diabetes mellitus patients: a systematic review. Cureus. 2024, 16:e66570. 10.7759\/cureus.66570","journal-title":"Cureus"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale HF","year":"2011","unstructured":"Escobar-Morreale HF, Luque-Ram\u00edrez M, Gonz\u00e1lez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011, 95:1048-58.e1-2. 10.1016\/j.fertnstert.2010.11.036","journal-title":"Fertil Steril"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.0522","article-title":"MOOSE reporting guidelines for meta-analyses of observational studies","volume":"156","author":"Brooke BS","year":"2021","unstructured":"Brooke BS, Schwartz TA, Pawlik TM. MOOSE reporting guidelines for meta-analyses of observational studies. JAMA Surg. 2021, 156:787-8. 10.1001\/jamasurg.2021.0522","journal-title":"JAMA Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348946-a-systematic-review-of-inflammatory-markers-in-polycystic-ovary-syndrome-pcos-and-meta-analysis-of-interleukin-6-il-6-in-case-control-studies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T08:59:18Z","timestamp":1744793958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348946-a-systematic-review-of-inflammatory-markers-in-polycystic-ovary-syndrome-pcos-and-meta-analysis-of-interleukin-6-il-6-in-case-control-studies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":54,"URL":"https:\/\/doi.org\/10.7759\/cureus.82350","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}